Literature DB >> 2174535

Clinical role of respiratory virus infection in acute otitis media.

M Arola1, O Ruuskanen, T Ziegler, J Mertsola, K Näntö-Salonen, A Putto-Laurila, M K Viljanen, P Halonen.   

Abstract

The clinical characteristics of acute otitis media in relation to coexisting respiratory virus infection were studied in a 1-year prospective study of 363 children with acute otitis media. Respiratory viruses were detected using virus isolation and virus antigen detection in nasopharyngeal specimens of 42% of the patients at the time of diagnosis. Rhinovirus (24%) and respiratory syncytial virus (13%) were the two most common viruses detected. Adenovirus, parainfluenza viruses, and coronavirus OC43 were found less frequently. The mean duration of preceding symptoms was 5.9 days before the diagnosis of acute otitis media. Ninety-four percent of the children had symptoms of upper respiratory tract infection. Fever was reported in 55% and earache in 47% of cases. Patients with respiratory syncytial virus infection had fever, cough, and vomiting significantly more often than patients with rhinovirus infection or virus-negative patients. No significant differences were found in the appearance of the tympanic membrane and outcome of illness between virus-negative and virus-positive patients with acute otitis. Most patients respond well to antimicrobial therapy despite the coexisting viral infection. If the symptoms of infection persist, they can be due to the underlying viral infection, and viral diagnostics preferably with rapid methods may be clinically useful in these patients.

Entities:  

Mesh:

Year:  1990        PMID: 2174535

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  18 in total

1.  The clinical course of bronchiolitis associated with acute otitis media.

Authors:  G Shazberg; S Revel-Vilk; D Shoseyov; A Ben-Ami; A Klar; H Hurvitz
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

2.  Evidence for transudation of specific antibody into the middle ears of parenterally immunized chinchillas after an upper respiratory tract infection with adenovirus.

Authors:  L O Bakaletz; K A Holmes
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

Review 3.  Antibiotics for acute otitis media in children.

Authors:  Roderick P Venekamp; Sharon L Sanders; Paul P Glasziou; Chris B Del Mar; Maroeska M Rovers
Journal:  Cochrane Database Syst Rev       Date:  2015-06-23

4.  Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus.

Authors:  Negin Gitiban; Joseph A Jurcisek; Randall H Harris; Sara E Mertz; Russell K Durbin; Lauren O Bakaletz; Joan E Durbin
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 5.  Antibiotic theory in otitis media.

Authors:  A Gungor; C D Bluestone
Journal:  Curr Allergy Asthma Rep       Date:  2001-07       Impact factor: 4.806

6.  Blinded multiplex PCR analyses of middle ear and nasopharyngeal fluids from chinchilla models of single- and mixed-pathogen-induced otitis media.

Authors:  L O Bakaletz; G J White; J C Post; G D Ehrlich
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

Review 7.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

Review 8.  Current research on respiratory viral infections: Fourth International Symposium.

Authors:  Michael G Ison; John Mills; Peter Openshaw; Maria Zambon; Albert Osterhaus; Frederick Hayden
Journal:  Antiviral Res       Date:  2002-08       Impact factor: 5.970

9.  Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media.

Authors:  K Suzuki; L O Bakaletz
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 10.  Importance of respiratory viruses in acute otitis media.

Authors:  Terho Heikkinen; Tasnee Chonmaitree
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.